Published in Lancet on November 05, 2005
Epigenetic Regulation of Human Adipose Tissue Distribution (Eiffel 2) | NCT02728635
Craving and Lifestyle Management Through Mindfulness Study (CALMM) | NCT01250509
Craving and Lifestyle Management Through Mindfulness Pilot Study (CALMM) | NCT00643344
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28
Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) (2008) 5.03
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol (2006) 4.02
New genetic loci link adipose and insulin biology to body fat distribution. Nature (2015) 3.38
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract (2013) 2.97
Obesity and socioeconomic status in developing countries: a systematic review. Obes Rev (2012) 2.88
Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71
Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC). Am J Clin Nutr (2015) 2.63
Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax (2006) 2.46
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31
Intima-media thickness in severe obesity: links with BMI and metabolic status but not with systemic or adipose tissue inflammation. Diabetes Care (2013) 2.10
The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med (2012) 2.09
Evaluation of community level interventions to address social and structural determinants of health: a cluster randomised controlled trial. BMC Public Health (2009) 2.05
Migraine and obesity: epidemiology, mechanisms, and implications. Headache (2009) 2.05
Overweight and obesity in eastern mediterranean region: prevalence and possible causes. J Obes (2011) 1.95
Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc (2009) 1.88
The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet (2015) 1.87
Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis (2008) 1.82
Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes (2010) 1.76
Do burdens of underweight and overweight coexist among lower socioeconomic groups in India? Am J Clin Nutr (2009) 1.74
Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr (2009) 1.73
Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ (2011) 1.70
Associations of job strain and lifestyle risk factors with risk of coronary artery disease: a meta-analysis of individual participant data. CMAJ (2013) 1.66
Is the body adiposity index (hip circumference/height(1.5)) more strongly related to skinfold thicknesses and risk factor levels than is BMI? The Bogalusa Heart Study. Br J Nutr (2012) 1.65
Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol (2007) 1.64
Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study. Heart (2014) 1.61
Correction of population stratification in large multi-ethnic association studies. PLoS One (2008) 1.59
Facets of personality linked to underweight and overweight. Psychosom Med (2009) 1.58
Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial. Diabetes Care (2012) 1.55
A farewell to body-mass index? Lancet (2005) 1.54
Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol (2014) 1.48
Waist circumference and waist-to-height ratio of Hong Kong Chinese children. BMC Public Health (2008) 1.48
Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis (2007) 1.46
A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Björknäs study. PLoS One (2009) 1.45
Prognostic impact of comorbidity in patients with bladder cancer. Eur Urol (2007) 1.45
The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ (2010) 1.45
Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial. Surg Obes Relat Dis (2011) 1.45
Obesity and functional disability in elderly Americans. J Am Geriatr Soc (2008) 1.43
The future of obesity reduction: beyond weight loss. Nat Rev Endocrinol (2009) 1.42
The association of body mass index and health-related quality of life in the general population: data from the 2003 Health Survey of England. Qual Life Res (2009) 1.40
Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol (2009) 1.40
Prevalence and risk factors associated with nutrition-related noncommunicable diseases in the Eastern Mediterranean region. Int J Gen Med (2012) 1.39
Children's binge eating and development of metabolic syndrome. Int J Obes (Lond) (2012) 1.38
The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med (2010) 1.37
Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey. PLoS One (2013) 1.37
Altered respiratory physiology in obesity. Can Respir J (2006) 1.35
Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. PLoS One (2011) 1.32
Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache (2009) 1.32
Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care (2013) 1.31
Obesity and dyslipidemia in South Asians. Nutrients (2013) 1.31
The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. J Gastroenterol (2012) 1.30
Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk. J Appl Physiol (1985) (2007) 1.30
Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease. Int J Obes (Lond) (2009) 1.30
Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab (2013) 1.29
Worksite interventions for preventing physical deterioration among employees in job-groups with high physical work demands: background, design and conceptual model of FINALE. BMC Public Health (2010) 1.29
Effects of physical activity, body mass index, waist-to-hip ratio and waist circumference on total mortality risk in the Swedish National March Cohort. Eur J Epidemiol (2010) 1.26
Increasing trends in central obesity among Chinese adults with normal body mass index, 1993-2009. BMC Public Health (2013) 1.24
Waist-to-height ratio, waist circumference, and body mass index as indices of cardiometabolic risk among 36,642 Taiwanese adults. Eur J Nutr (2011) 1.23
Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002-2006. Eur J Epidemiol (2009) 1.22
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail (2011) 1.22
Inflammation, obesity, and thrombosis. Blood (2013) 1.21
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women. J Womens Health (Larchmt) (2011) 1.21
The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol (2012) 1.21
A cardiologist's guide to waist management. Heart (2006) 1.20
An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss. Genome Biol (2015) 1.19
Biology of upper-body and lower-body adipose tissue--link to whole-body phenotypes. Nat Rev Endocrinol (2014) 1.18
The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists. Gastroenterol Hepatol (N Y) (2010) 1.17
Relationship between fibromyalgia and obesity in pain, function, mood, and sleep. J Pain (2010) 1.17
Body mass index relates to blood pressure among adults. N Am J Med Sci (2014) 1.15
Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE. Eur J Cardiovasc Prev Rehabil (2011) 1.15
Body adiposity index and cardiovascular health risk factors in Caucasians: a comparison with the body mass index and others. PLoS One (2013) 1.14
A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut (2011) 1.14
Is weight loss the optimal target for obesity-related cardiovascular disease risk reduction? Can J Cardiol (2008) 1.14
Improved delivery of cardiovascular care (IDOCC) through outreach facilitation: study protocol and implementation details of a cluster randomized controlled trial in primary care. Implement Sci (2011) 1.13
Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol (2009) 1.10
Body circumferences: clinical implications emerging from a new geometric model. Nutr Metab (Lond) (2008) 1.10
Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep (2007) 1.09
Change in the body mass index distribution for women: analysis of surveys from 37 low- and middle-income countries. PLoS Med (2013) 1.09
The impact of weight gain on motivation, compliance, and metabolic control in patients with type 2 diabetes mellitus. Postgrad Med (2009) 1.08
Gender differences in obesogenic behaviour, socioeconomic and metabolic factors in a population-based sample of Iranians: the IHHP study. J Health Popul Nutr (2010) 1.06
Complete health checkup for adults: Update on the Preventive Care Checklist Form. Can Fam Physician (2008) 1.06
Genetic influences on type 2 diabetes and metabolic syndrome related quantitative traits in Mauritius. Twin Res Hum Genet (2009) 1.06
Associations of large artery structure and function with adiposity: effects of age, gender, and hypertension. The SardiNIA Study. Atherosclerosis (2011) 1.06
The relationship between body size and mortality in the linked Scottish Health Surveys: cross-sectional surveys with follow-up. Int J Obes (Lond) (2010) 1.05
Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol (2014) 1.05
Femoral adipose tissue may accumulate the fat that has been recycled as VLDL and nonesterified fatty acids. Diabetes (2010) 1.04
The relationship between various measures of obesity and arterial stiffness in morbidly obese patients. BMC Cardiovasc Disord (2011) 1.04
Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans. Diabetes (2012) 1.04
"A Body Shape Index" in middle-age and older Indonesian population: scaling exponents and association with incident hypertension. PLoS One (2014) 1.03
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). Am J Cardiol (2012) 1.03
Abdominal obesity: the cholesterol of the 21st century? Can J Cardiol (2008) 1.03
Comparison of various anthropometric and body fat indices in identifying cardiometabolic disturbances in Chinese men and women. PLoS One (2013) 1.03
Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: Stability of metabolic health status in adults. Obesity (Silver Spring) (2015) 1.03
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.02
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med (2009) 8.73
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One (2008) 7.16
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet (2010) 7.08
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet (2006) 5.85
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32
Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA (2003) 5.18
Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J (2007) 4.88
A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med (2009) 4.80
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet (2010) 4.74
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med (2010) 4.73
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med (2010) 4.52
Defining obesity cut points in a multiethnic population. Circulation (2007) 4.42
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet (2008) 4.37
Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation (2005) 4.21
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 4.10
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet (2007) 4.09
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Reconstructing angina: cardiac symptoms are the same in women and men. JAMA Intern Med (2013) 3.97
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet (2015) 3.79
Obesity prevalence from a European perspective: a systematic review. BMC Public Health (2008) 3.67
Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J (2008) 3.64
Valsartan for prevention of recurrent atrial fibrillation. N Engl J Med (2009) 3.60
Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med (2005) 3.38
Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis (2013) 3.27
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation (2013) 3.25
Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol (2007) 3.23
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation (2006) 3.22
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation (2008) 3.19
CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology (2013) 3.01
Activation of the peripheral endocannabinoid system in human obesity. Diabetes (2005) 2.90
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation (2002) 2.89
Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation (2010) 2.88
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA (2004) 2.87
Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol (2005) 2.76
Specific barriers to the conduct of randomized trials. Clin Trials (2008) 2.68
Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. J Am Coll Cardiol (2010) 2.66
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation (2013) 2.64
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Weight loss and the renin-angiotensin-aldosterone system. Hypertension (2005) 2.58
Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol (2005) 2.56
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke (2013) 2.52
Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation (2003) 2.49
Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease. J Am Coll Cardiol (2012) 2.47
A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg (2010) 2.41
World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol (2010) 2.38
Periadventitial fat releases a vascular relaxing factor. FASEB J (2002) 2.29
Does the clinical examination predict lower extremity peripheral arterial disease? JAMA (2006) 2.29
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes (2011) 2.21
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Retinol-binding protein 4 in human obesity. Diabetes (2006) 2.17
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Association between adiponectin and mediators of inflammation in obese women. Diabetes (2003) 2.05
Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care (2013) 2.04
Non-steroidal anti-inflammatory drugs and cardiovascular risk. S Afr Med J (2007) 2.02
[On therapeutic enthusiasm again, this time in arterial hypertension]. Lijec Vjesn (2014) 2.01
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96
Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis (2010) 1.95
Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care (2003) 1.93
[The role of omega-3 fatty acids from fish in cardiovascular prevention]. Lijec Vjesn (2008) 1.93
Natural history and management of aortocoronary saphenous vein graft aneurysms: a systematic review of published cases. Circulation (2012) 1.93
Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res (2004) 1.91
The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J Lipid Res (2009) 1.90
The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med (2009) 1.89
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care (2009) 1.89